| Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study D Nepogodiev, A Bhangu, JC Glasbey, E Li, OM Omar, JFF Simoes, ... The Lancet 396 (10243), 27-38, 2020 | 1811 | 2020 |
| A multisociety Delphi consensus statement on new fatty liver disease nomenclature ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, ... Hepatology 78 (6), 1966-1986, 2023 | 1160 | 2023 |
| Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study H Gacaferi, GS Collaborative, COVIDSurg Collaborative Anaesthesia 76 (6), 2021 | 534* | 2021 |
| High rates of 30-day mortality in patients with cirrhosis and COVID-19 M Iavarone, R D'Ambrosio, A Soria, M Triolo, N Pugliese, P Del Poggio, ... Journal of hepatology 73 (5), 1063-1071, 2020 | 384 | 2020 |
| Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical … JM Dumonceau, M Polkowski, A Larghi, P Vilmann, M Giovannini, ... Endoscopy, 897-912, 2011 | 360 | 2011 |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 234 | 2021 |
| Hepatitis C infection in Egypt: prevalence, impact and management strategies A Gomaa, N Allam, A Elsharkway, M El Kassas, I Waked Hepatic medicine: evidence and research, 17-25, 2017 | 209 | 2017 |
| National treatment programme of hepatitis C in Egypt: hepatitis C virus model of care W El‐Akel, MH El‐Sayed, M El Kassas, M El‐Serafy, M Khairy, K Elsaeed, ... Journal of viral hepatitis 24 (4), 262-267, 2017 | 202 | 2017 |
| A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis SS El-Kamary, MD Shardell, M Abdel-Hamid, S Ismail, M El-Ateek, ... Phytomedicine 16 (5), 391-400, 2009 | 187 | 2009 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 166 | 2022 |
| Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective … BM Biccard, PD Gopalan, M Miller, WL Michell, D Thomson, A Ademuyiwa, ... The Lancet 397 (10288), 1885-1894, 2021 | 153 | 2021 |
| Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations D Omran, M Alboraie, RA Zayed, MN Wifi, M Naguib, M Eltabbakh, ... World journal of gastroenterology 24 (38), 4330, 2018 | 147 | 2018 |
| Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real‐world results from 18 378 patients in Egypt H Omar, W El Akel, T Elbaz, M El Kassas, K Elsaeed, H El Shazly, M Said, ... Alimentary pharmacology & therapeutics 47 (3), 421-431, 2018 | 137 | 2018 |
| Effects of alcohol consumption and metabolic syndrome on mortality in patients with nonalcoholic and alcohol-related fatty liver disease ZM Younossi, M Stepanova, J Ong, Y Yilmaz, A Duseja, Y Eguchi, ... Clinical Gastroenterology and Hepatology 17 (8), 1625-1633. e1, 2019 | 129 | 2019 |
| Alcohol-related liver disease is rarely detected at early stages compared with liver diseases of other etiologies worldwide ND Shah, M Ventura-Cots, JG Abraldes, M Alboraie, A Alfadhli, J Argemi, ... Clinical Gastroenterology and Hepatology 17 (11), 2320-2329. e12, 2019 | 109 | 2019 |
| SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. C COVIDSurg, C GlobalSurg Anaesthesia 77 (1), 28-39, 2022 | 100 | 2022 |
| COVID-19 in Egypt: Uncovered figures or a different situation? MA Medhat, M El Kassas Journal of global health 10 (1), 2020 | 100 | 2020 |
| Increased recurrence rates of hepatocellular carcinoma after DAA therapy in a hepatitis C‐infected Egyptian cohort: a comparative analysis M El Kassas, AL Funk, M Salaheldin, Y Shimakawa, M Eltabbakh, K Jean, ... Journal of viral hepatitis 25 (6), 623-630, 2018 | 93 | 2018 |
| Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis V Sapena, M Enea, F Torres, C Celsa, J Rios, GEM Rizzo, P Nahon, ... Gut 71 (3), 593-604, 2022 | 78 | 2022 |
| New era for management of chronic hepatitis C virus using direct antiviral agents: a review T Elbaz, M El-Kassas, G Esmat Journal of advanced research 6 (3), 301-310, 2015 | 70 | 2015 |
Mohamed AlboraieDepartment of Internal Medicine, Al-Azhar University, Cairo, EgyptAdresse e-mail validée de azhar.edu.eg
